Solstein Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1K Hold
371
0.01% 258
2025
Q4
$35.6K Hold
371
0.01% 239
2025
Q3
$35.3K Sell
371
-355
-49% -$32.6K 0.01% 228
2025
Q2
$63.3K Buy
+726
New +$61.6K 0.03% 179
2022
Q3
Sell
-280
Closed -$25K 326
2022
Q2
$25K Hold
280
0.02% 214
2022
Q1
$31K Sell
280
-300
-52% -$31.7K 0.02% 235
2021
Q4
$60K Sell
580
-200
-26% -$23.2K 0.04% 199
2021
Q3
$98K Hold
780
0.06% 175
2021
Q2
$97K Buy
780
+500
+179% +$62.8K 0.12% 160
2021
Q1
$33K Buy
+280
New +$32.8K 0.04% 224
2020
Q2
Sell
-78
Closed -$7K 277
2020
Q1
$7K Sell
78
-351
-82% -$37.3K 0.03% 206
2019
Q4
$49K Buy
+429
New +$47.1K 0.1% 113

Other funds holding MDT

Solstein Capital's MDT Position: Q1 2026 in Review

Solstein Capital held its Medtronic (MDT) position steady in Q1 2026 at 371 shares worth $32.1K. The position accounts for 0.01% of the portfolio, ranked #258.

Solstein Capital first reported a position in MDT in Q4 2019 and has held it in 12 quarters since. The position peaked at $98K in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Solstein Capital held 371 shares of Medtronic worth $32.1K as of Q1 2026.
  • Solstein Capital left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up 0.01% of Solstein Capital's portfolio in Q1 2026, its #258 holding.
  • Solstein Capital first reported a position in Medtronic in Q4 2019 and has held it in 12 quarters since.
  • Solstein Capital's Medtronic position peaked at $98K in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.